Snooker: A structure-based pharmacophore generation tool applied to class A GPCRs

Journal of Chemical Information and Modeling

Volumn 51, Issue 9, 2011, Pages 2277-2292

  Sanders, Marijn P A ^a   Verhoeven, Stefan ^b   De Graaf, Chris ^c   Roumen, Luc ^c   Vroling, Bas ^a   Nabuurs, Sander B ^a   De Vlieg, Jacob ^a,b   Klomp, Jan P G ^b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b MSD   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; BINDING ENERGY; LIGANDS; PROTEINS; SPORTS;

ADRENERGIC RECEPTORS; COMPOUND SELECTION; ENRICHMENT FACTORS; G PROTEIN COUPLED RECEPTORS; MUTAGENESIS EXPERIMENT; PHARMACEUTICAL COMPANY; PROTEIN-LIGAND INTERACTIONS; TRANSMEMBRANE DOMAIN;

PHARMACODYNAMICS;

G PROTEIN COUPLED RECEPTOR; LIGAND;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; MUTAGENESIS; PROTEIN BINDING; PROTEIN CONFORMATION;

LIGANDS; MODELS, MOLECULAR; MUTAGENESIS; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED;

EID: 80053297434     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci200088d     Document Type: Article

References (96)

1. Klabunde, T.; Hessler, G. Drug design strategies for targeting G-protein-coupled receptors ChemBioChem 2002, 3, 928-944 (Pubitemid 35189597)
2. Hopkins, A. L.; Groom, C. R. The druggable genome Nat. Rev. Drug Discovery 2002, 1, 727-730 (Pubitemid 37361545)
3. Franke, L.; Byvatov, E.; Werz, O.; Steinhilber, D.; Schneider, P.; Schneider, G. Extraction and visualization of potential pharmacophore points using support vector machines: application to ligand-based virtual screening for COX-2 inhibitors J. Med. Chem. 2005, 48, 6997-7004 (Pubitemid 41533121)
4. Marrero-Ponce, Y.; Iyarreta-Veitia, M.; Montero-Torres, A.; Romero-Zaldivar, C.; Brandt, C. A.; Avila, P. E.; Kirchgatter, K.; Machado, Y. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps J. Chem. Inf. Model. 2005, 45, 1082-1100 (Pubitemid 41156709)
5. Schuster, D.; Maurer, E. M.; Laggner, C.; Nashev, L. G.; Wilckens, T.; Langer, T.; Odermatt, A. The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening J. Med. Chem. 2006, 49, 3454-3466 (Pubitemid 43904337)
6. Evers, A.; Hessler, G.; Matter, H.; Klabunde, T. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols J. Med. Chem. 2005, 48, 5448-5465 (Pubitemid 41209243)
7. Schneider, G.; Nettekoven, M. Ligand-based combinatorial design of selective purinergic receptor (A2A) antagonists using self-organizing maps J. Comb. Chem. 2003, 5, 233-237 (Pubitemid 37140569)
8. Oloff, S.; Mailman, R. B.; Tropsha, A. Application of validated QSAR models of D1 dopaminergic antagonists for database mining J. Med. Chem. 2005, 48, 7322-7332 (Pubitemid 41743646)
9. Zhang, Q.; Muegge, I. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring J. Med. Chem. 2006, 49, 1536-1548 (Pubitemid 43376501)
10. Oprea, T. I.; Matter, H. Integrating virtual screening in lead discovery Curr. Opin. Chem. Biol. 2004, 8, 349-358 (Pubitemid 38996798)
11. Congreve, M.; Murray, C. W.; Blundell, T. L. Structural biology and drug discovery Drug Discovery Today 2005, 10, 895-907
12. Jorgensen, W. L. The many roles of computation in drug discovery Science 2004, 303, 1813-1818 (Pubitemid 38374866)
13. Hou, T.; Xu, X. Recent development and application of virtual screening in drug discovery: an overview Curr. Pharm. Des. 2004, 10, 1011-1033 (Pubitemid 38380079)
14. de Graaf, C.; Rognan, D. Customizing G Protein-coupled receptor models for structure-based virtual screening Curr. Pharm. Des. 2009, 15, 4026-4048
15. Kolb, P.; Rosenbaum, D. M.; Irwin, J. J.; Fung, J. J.; Kobilka, B. K.; Shoichet, B. K. Structure-based discovery of beta2-adrenergic receptor ligands Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 6843-6848
16. Katritch, V.; Jaakola, V. P.; Lane, J. R.; Lin, J.; Ijzerman, A. P.; Yeager, M.; Kufareva, I.; Stevens, R. C.; Abagyan, R. Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists J. Med. Chem. 2010, 53, 1799-1809
17. Nabuurs, S. B.; Wagener, M.; de Vlieg, J. A flexible approach to induced fit docking J. Med. Chem. 2007, 50, 6507-6518 (Pubitemid 350309091)
18. Crossley, R. The design of screening libraries targeted at G-protein coupled receptors Curr. Top. Med. Chem. 2004, 4, 581-588 (Pubitemid 38842578)
19. Salo, O. M.; Raitio, K. H.; Savinainen, J. R.; Nevalainen, T.; Lahtela-Kakkonen, M.; Laitinen, J. T.; Jarvinen, T.; Poso, A. Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor J. Med. Chem. 2005, 48, 7166-7171 (Pubitemid 41743629)
20. Kenyon, V.; Chorny, I.; Carvajal, W. J.; Holman, T. R.; Jacobson, M. P. Novel human lipoxygenase inhibitors discovered using virtual screening with homology models J. Med. Chem. 2006, 49, 1356-1363 (Pubitemid 43271887)
21. Bissantz, C.; Bernard, P.; Hibert, M.; Rognan, D. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets? Proteins 2003, 50, 5-25 (Pubitemid 36090604)
22. Bissantz, C.; Logean, A.; Rognan, D. High-throughput modeling of human G-protein coupled receptors: amino acid sequence alignment, three-dimensional model building, and receptor library screening J. Chem. Inf. Comput. Sci. 2004, 44, 1162-1176
23. Kratochwil, N. A.; Malherbe, P.; Lindemann, L.; Ebeling, M.; Hoener, M. C.; Muhlemann, A.; Porter, R. H.; Stahl, M.; Gerber, P. R. An automated system for the analysis of G protein-coupled receptor transmembrane binding pockets: alignment, receptor-based pharmacophores, and their application J. Chem. Inf. Model. 2005, 45, 1324-1336 (Pubitemid 41476016)
24. Klabunde, T.; Giegerich, C.; Evers, A. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening J. Med. Chem. 2009, 52, 2923-2932
25. Tsai, K. C.; Chen, S. Y.; Liang, P. H.; Lu, I. L.; Mahindroo, N.; Hsieh, H. P.; Chao, Y. S.; Liu, L.; Liu, D.; Lien, W.; Lin, T. H.; Wu, S. Y. Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies J. Med. Chem. 2006, 49, 3485-3495 (Pubitemid 43902455)
26. Bologa, C. G.; Revankar, C. M.; Young, S. M.; Edwards, B. S.; Arterburn, J. B.; Kiselyov, A. S.; Parker, M. A.; Tkachenko, S. E.; Savchuck, N. P.; Sklar, L. A.; Oprea, T. I.; Prossnitz, E. R. Virtual and biomolecular screening converge on a selective agonist for GPR30 Nat. Chem. Biol. 2006, 2, 207-212
27. Overington, J. P.; Al-Lazikani, B.; Hopkins, A. L. How many drug targets are there? Nat. Rev. Drug. Discovery 2006, 5, 993-996 (Pubitemid 44835126)
28. Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. DrugBank 3.0: a comprehensive resource for omics research on drugs Nucleic Acids Res. 2011, 39, D1035-1041
29. Chen, X.; Lin, Y.; Gilson, M. K. The binding database: overview and users guide Biopolymers 2001, 61, 127-141 (Pubitemid 34292948)
30. Chen, X.; Lin, Y.; Liu, M.; Gilson, M. K. The Binding Database: data management and interface design Bioinformatics 2002, 18, 130-139 (Pubitemid 34145041)
31. Chen, X.; Liu, M.; Gilson, M. K. BindingDB: a web-accessible molecular recognition database Comb. Chem. High Throughput Screening 2001, 4, 719-725 (Pubitemid 34003162)
32. Wang, R.; Fang, X.; Lu, Y.; Wang, S. The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures J. Med. Chem. 2004, 47, 2977-2980 (Pubitemid 38702694)
33. Wang, R.; Fang, X.; Lu, Y.; Yang, C. Y.; Wang, S. The PDBbind database: methodologies and updates J. Med. Chem. 2005, 48, 4111-4119 (Pubitemid 40800619)
34. Hu, L.; Benson, M. L.; Smith, R. D.; Lerner, M. G.; Carlson, H. A. Binding MOAD (Mother Of All Databases) Proteins 2005, 60, 333-340 (Pubitemid 41061630)
35. Smith, R. D.; Hu, L.; Falkner, J. A.; Benson, M. L.; Nerothin, J. P.; Carlson, H. A. Exploring protein-ligand recognition with Binding MOAD J. Mol. Graphics Modell. 2006, 24, 414-425
36. Oprea, T. I.; Allu, T. K.; Fara, D. C.; Rad, R. F.; Ostopovici, L.; Bologa, C. G. Lead-like, drug-like or "Pub-like": how different are they? J. Comput.-Aided Mol. Des. 2007z, 21, 113-119 (Pubitemid 46416670)
37. Okuno, Y.; Tamon, A.; Yabuuchi, H.; Niijima, S.; Minowa, Y.; Tonomura, K.; Kunimoto, R.; Feng, C. GLIDA: GPCR - ligand database for chemical genomics drug discovery - database and tools update Nucleic Acids Res. 2008, 36, D907-912
38. Sanders, M. P.; Fleuren, W. W.; Verhoeven, S.; van den Beld, S.; Alkema, W.; de Vlieg, J.; Klomp, J. P. ss-TEA: Entropy based identification of receptor specific ligand binding residues from a multiple sequence alignment of class A GPCRs BMC Bioinf. 2011, 12, 332
39. Li, J.; Edwards, P. C.; Burghammer, M.; Villa, C.; Schertler, G. F. Structure of bovine rhodopsin in a trigonal crystal form J. Mol. Biol. 2004, 343, 1409-1438 (Pubitemid 39387834)
40. Ballesteros, J. A. W. H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein coupled receptors Methods Neurosci. 1995, 25, 366-428
41. Chinea, G.; Padron, G.; Hooft, R. W.; Sander, C.; Vriend, G. The use of position-specific rotamers in model building by homology Proteins 1995, 23, 415-421
42. Lovell, S. C.; Word, J. M.; Richardson, J. S.; Richardson, D. C. The penultimate rotamer library Proteins 2000, 40, 389-408 (Pubitemid 30624447)
43. Madabushi, S.; Gross, A. K.; Philippi, A.; Meng, E. C.; Wensel, T. G.; Lichtarge, O. Evolutionary trace of G protein-coupled receptors reveals clusters of residues that determine global and class-specific functions J. Biol. Chem. 2004, 279, 8126-8132 (Pubitemid 38294703)
44. Oliveira, L.; Paiva, P. B.; Paiva, A. C.; Vriend, G. Sequence analysis reveals how G protein-coupled receptors transduce the signal to the G protein Proteins 2003, 52, 553-560 (Pubitemid 37034153)
45. Ye, K.; Lameijer, E. W.; Beukers, M. W.; Ijzerman, A. P. A two-entropies analysis to identify functional positions in the transmembrane region of class A G protein-coupled receptors Proteins 2006, 63, 1018-1030 (Pubitemid 43765152)
46. Bohm, B.; Aigner, T.; Kinne, R.; Burkhardt, H. The serine-protease inhibitor of cartilage matrix is not a chondrocytic gene product Eur. J. Biochem. 1992, 207, 773-779
47. Gunzer, F.; Bohm, H.; Russmann, H.; Bitzan, M.; Aleksic, S.; Karch, H. Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome J. Clin. Microbiol. 1992, 30, 1807-1810
48. Bohm, H. J. The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure J. Comput.-Aided Mol. Des. 1994, 8, 243-256
49. Klebe, G. The use of composite crystal-field environments in molecular recognition and the de novo design of protein ligands J. Mol. Biol. 1994, 237, 212-235 (Pubitemid 24182235)
50. Rarey, M.; Kramer, B.; Lengauer, T.; Klebe, G. A fast flexible docking method using an incremental construction algorithm J. Mol. Biol. 1996, 261, 470-489 (Pubitemid 26335901)
51. Ye, K.; Feenstra, K. A.; Heringa, J.; Ijzerman, A. P.; Marchiori, E. Multi-RELIEF: a method to recognize specificity determining residues from multiple sequence alignments using a Machine-Learning approach for feature weighting Bioinformatics 2008, 24, 18-25
52. Barillari, C.; Marcou, G.; Rognan, D. Hot-spots-guided receptor-based pharmacophores (HS-Pharm): a knowledge-based approach to identify ligand-anchoring atoms in protein cavities and prioritize structure-based pharmacophores J. Chem. Inf. Model. 2008, 48, 1396-1410
53. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules J. Med. Chem. 1985, 28, 849-857 (Pubitemid 15012490)
54. Verdonk, M. L.; Cole, J. C.; Taylor, R. SuperStar: a knowledge-based approach for identifying interaction sites in proteins J. Mol. Biol. 1999, 289, 1093-1108 (Pubitemid 29306672)
55. de Graaf, C.; Rognan, D. Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor J. Med. Chem. 2008, 51, 4978-4985
56. Chien, E. Y.; Liu, W.; Zhao, Q.; Katritch, V.; Han, G. W.; Hanson, M. A.; Shi, L.; Newman, A. H.; Javitch, J. A.; Cherezov, V.; Stevens, R. C. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist Science 2010, 330, 1091-1095
57. Wu, B.; Chien, E. Y.; Mol, C. D.; Fenalti, G.; Liu, W.; Katritch, V.; Abagyan, R.; Brooun, A.; Wells, P.; Bi, F. C.; Hamel, D. J.; Kuhn, P.; Handel, T. M.; Cherezov, V.; Stevens, R. C. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Science 2010, 330, 1066-1071
58. Kufareva, I.; Rueda, R.; Katritch, V. GPCR Dock 2010 participants, Stevens, C. S.; Abagyan, R. Status of GPCR modeling and docking in a community wide GPCR dock 2010 assessment Structure 2011, 19, 1108-1126
59. Vroling, B.; Sanders, M.; Baakman, C.; Borrmann, A.; Verhoeven, S.; Klomp, J.; Oliveira, L.; de Vlieg, J.; Vriend, G. GPCRDB: information system for G protein-coupled receptors Nucleic Acids Res. 2010, 39, 1-11
60. Leach, A. R.; Gillet, V. J.; Lewis, R. A.; Taylor, R. Three-dimensional pharmacophore methods in drug discovery J. Med. Chem. 2010, 53, 539-558
61. Okada, T.; Fujiyoshi, Y.; Silow, M.; Navarro, J.; Landau, E. M.; Shichida, Y. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 5982-5987 (Pubitemid 34493251)
62. Cherezov, V.; Rosenbaum, D. M.; Hanson, M. A.; Rasmussen, S. G.; Thian, F. S.; Kobilka, T. S.; Choi, H. J.; Kuhn, P.; Weis, W. I.; Kobilka, B. K.; Stevens, R. C. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor Science 2007, 318, 1258-1265 (Pubitemid 350172884)
63. Warne, T.; Serrano-Vega, M. J.; Baker, J. G.; Moukhametzianov, R.; Edwards, P. C.; Henderson, R.; Leslie, A. G.; Tate, C. G.; Schertler, G. F. Structure of a beta1-adrenergic G-protein-coupled receptor Nature 2008, 454, 486-491
64. Park, J. H.; Scheerer, P.; Hofmann, K. P.; Choe, H. W.; Ernst, O. P. Crystal structure of the ligand-free G-protein-coupled receptor opsin Nature 2008, 454, 183-187 (Pubitemid 351969893)
65. Hanson, M. A.; Cherezov, V.; Griffith, M. T.; Roth, C. B.; Jaakola, V. P.; Chien, E. Y.; Velasquez, J.; Kuhn, P.; Stevens, R. C. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor Structure 2008, 16, 897-905 (Pubitemid 351778384)
66. Scheerer, P.; Park, J. H.; Hildebrand, P. W.; Kim, Y. J.; Krauss, N.; Choe, H. W.; Hofmann, K. P.; Ernst, O. P. Crystal structure of opsin in its G-protein-interacting conformation Nature 2008, 455, 497-502
67. Jaakola, V. P.; Griffith, M. T.; Hanson, M. A.; Cherezov, V.; Chien, E. Y.; Lane, J. R.; Ijzerman, A. P.; Stevens, R. C. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist Science 2008, 322, 1211-1217
68. Needleman, S. B.; Wunsch, C. D. A general method applicable to the search for similarities in the amino acid sequence of two proteins J. Mol. Biol. 1970, 48, 443-453
69. Krieger, E.; Koraimann, G.; Vriend, G. Increasing the precision of comparative models with YASARA NOVA - a self-parameterizing force field Proteins 2002, 47, 393-402 (Pubitemid 34438688)
70. Vriend, G. WHAT IF: a molecular modeling and drug design program J. Mol. Graphics 1990, 8 (52-56) 29
71. Delaunay, B. Sur la sphère vide Izvestia Akademii Nauk SSSR, Otdelenie Matematicheskikh i Estestvennykh Nauk 1934, 7, 793-800
72. Kumar, S.; Nussinov, R. Relationship between ion pair geometries and electrostatic strengths in proteins Biophys. J. 2002, 83, 1595-1612 (Pubitemid 34977731)
73. Renner, S.; Schneider, G. Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening J. Med. Chem. 2004, 47, 4653-4664 (Pubitemid 39195556)
74. Breu, V.; Hashido, K.; Broger, C.; Miyamoto, C.; Furuichi, Y.; Hayes, A.; Kalina, B.; Loffler, B. M.; Ramuz, H.; Clozel, M. Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptors Eur. J. Biochem. 1995, 231, 266-270
75. Shi, L.; Javitch, J. A. The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop Annu. Rev. Pharmacol. Toxicol. 2002, 42, 437-467 (Pubitemid 34162546)
76. Kane, B. E.; Svensson, B.; Ferguson, D. M. Molecular recognition of opioid receptor ligands AAPS J. 2006, 8, E126-137
77. Li, J. G.; Chen, C.; Yin, J.; Rice, K.; Zhang, Y.; Matecka, D.; de Riel, J. K.; DesJarlais, R. L.; Liu-Chen, L. Y. ASP147 in the third transmembrane helix of the rat mu opioid receptor forms ion-pairing with morphine and naltrexone Life Sci. 1999, 65, 175-185 (Pubitemid 29292820)
78. Surratt, C. K.; Johnson, P. S.; Moriwaki, A.; Seidleck, B. K.; Blaschak, C. J.; Wang, J. B.; Uhl, G. R. -mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity J. Biol. Chem. 1994, 269, 20548-20553
79. Sadowski, J.; Gasteiger, J.; Klebe, G. Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures J. Chem. Inf. Comput. Sci. 1994, 34, 8
80. Liu, X.; Bai, F.; Ouyang, S.; Wang, X.; Li, H.; Jiang, H. Cyndi: a multi-objective evolution algorithm based method for bioactive molecular conformational generation BMC Bioinf. 2009, 10, 101
81. Pipeline Pilot, version 8.0; Accelrys: San Diego, CA, 2010.
82. Canutescu, A. A.; Shelenkov, A. A.; Dunbrack, R. L., Jr. A graph-theory algorithm for rapid protein side-chain prediction Protein Sci. 2003, 12, 2001-2014 (Pubitemid 37022822)
83. Warne, T.; Moukhametzianov, R.; Baker, J. G.; Nehme, R.; Edwards, P. C.; Leslie, A. G.; Schertler, G. F.; Tate, C. G. The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor Nature 2011, 469, 241-244
84. Krieger, E.; Joo, K.; Lee, J.; Raman, S.; Thompson, J.; Tyka, M.; Baker, D.; Karplus, K. Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8 Proteins 2009, 77 (Suppl 9) 114-122
85. Clark, R. D.; Webster-Clark, D. J. Managing bias in ROC curves J. Comput.-Aided Mol. Des. 2008, 22, 141-146
86. Jain, A. N.; Nicholls, A. Recommendations for evaluation of computational methods J. Comput.-Aided Mol. Des. 2008, 22, 133-139
87. Landrum, G. RDKit, Q2 2010 1; Palo Alto, CA 94301, USA.
88. Staubert, C.; Boselt, I.; Bohnekamp, J.; Rompler, H.; Enard, W.; Schoneberg, T. Structural and functional evolution of the trace amine-associated receptors TAAR3, TAAR4 and TAAR5 in primates. PLoS One 5, e11133.
89. Rosenbaum, D. M.; Cherezov, V.; Hanson, M. A.; Rasmussen, S. G.; Thian, F. S.; Kobilka, T. S.; Choi, H. J.; Yao, X. J.; Weis, W. I.; Stevens, R. C.; Kobilka, B. K. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function Science 2007, 318, 1266-1273 (Pubitemid 350172885)
90. Holst, B.; Frimurer, T. M.; Mokrosinski, J.; Halkjaer, T.; Cullberg, K. B.; Underwood, C. R.; Schwartz, T. W. Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor Mol. Pharmacol. 2009, 75, 44-59
91. Macdonald, D.; Murgolo, N.; Zhang, R.; Durkin, J. P.; Yao, X.; Strader, C. D.; Graziano, M. P. Molecular characterization of the melanin-concentrating hormone/receptor complex: identification of critical residues involved in binding and activation Mol. Pharmacol. 2000, 58, 217-225 (Pubitemid 30452545)
92. Fierens, F. L.; Vanderheyden, P. M.; Gaborik, Z.; Minh, T. L.; Backer, J. P.; Hunyady, L.; Ijzerman, A.; Vauquelin, G. Lys(199) mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists J. Renin Angiotensin Aldosterone Syst. 2000, 1, 283-288
93. Khasawneh, F. T.; Huang, J. S.; Turek, J. W.; Le Breton, G. C. Differential mapping of the amino acids mediating agonist and antagonist coordination with the human thromboxane A2 receptor protein J. Biol. Chem. 2006, 281, 26951-26965 (Pubitemid 44401724)
94. Xu, F.; Wu, H.; Katritch, V.; Han, G. W.; Jacobson, K. A.; Gao, Z. G.; Cherezov, V.; Stevens, R. C. Structure of an agonist-bound human A2A adenosine receptor Science 2011, 332, 322-327
95. Muegge, I.; Oloff, S. Advances in virtual screening Drug Discovery Today: Technol. 2006, 3, 405-411 (Pubitemid 46164322)
96. Ortore, G.; Tuccinardi, T.; Orlandini, E.; Martinelli, A. Different Binding Modes of Structurally Diverse Ligands for Human D3DAR J. Chem. Inf. Model. 2010, 50, 2162-2175